Factors Associated with Improvements in Patient-Reported Outcomes During Mirabegron or Antimuscarinic Treatment of Overactive Bladder Syndrome: A Registry Study (PERSPECTIVE).Published in:2019By:Carlson, Kevin V.;Rovner, Eric S.;Nair, Kavita V.;Deal, Anna S.;Kristy, Rita M.;Schermer, Carol R.Publication type:journal article
Persistence with mirabegron or antimuscarinic treatment for overactive bladder syndrome: Findings from the PERSPECTIVE registry study.Published in:LUTS (1757-5664), 2021, v. 13, n. 4, p. 425, doi. 10.1111/luts.12382By:Carlson, Kevin V.;Rovner, Eric S.;Nair, Kavita V.;Deal, Anna S.;Kristy, Rita M.;Hairston, John C.Publication type:Article